Clinical and bacteriological evaluation of intravenous doxycycline in severe hospital infections.
D000284:Administration, Oral; D000328:Adult; D000368:Aged; D001424:Bacterial Infections / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D003428:Cross Infection / Q000188:drug therapy*; D004318:Doxycycline / Q000097:blood / Q000494:pharmacology / Q000627:therapeutic use / Q000652:urine; D004352:Drug Resistance, Microbial; D004926:Escherichia coli / Q000187:drug effects; D005069:Evaluation Studies as Topic; D005260:Female; D006801:Humans; D007275:Injections, Intravenous; D007709:Klebsiella / Q000187:drug effects; D008297:Male; D008826:Microbial Sensitivity Tests; D008875:Middle Aged; D010118:Oxytetracycline / Q000627:therapeutic use*; D011513:Proteus mirabilis / Q000187:drug effects; D011550:Pseudomonas aeruginosa / Q000187:drug effects; D013210:Staphylococcus / Q000187:drug effects; D013291:Streptococcus / Q000187:drug effects; D013296:Streptococcus pneumoniae / Q000187:drug effects; D013997:Time Factors
D004318:Doxycycline; D010118:Oxytetracycline